About: desirudin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: desirudin Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

pharmaceutic drug

Attributes	Values
rdf:type	Item
description	pharmaceutic drug (en)
rdfs:label	desirudin (en) desirudina (ca) désirudine (fr)
skos:prefLabel	desirudin (en) desirudina (ca) désirudine (fr)
name	desirudin (en) desirudina (ca) désirudine (fr)
subject has role	wds:Q28852444-1127D80E-D543-46F6-B204-276341E4EB17 wds:Q28852444-CC3FC018-DA08-4A4C-B1FD-56116708718A
subject has role	anticoagulant fibrinolytic agents
ATC code	wds:Q28852444-C1F6B5CA-E07E-4E87-83C5-791BF4162210
defined daily dose	wds:Q28852444-6CE8D980-4FC3-4653-872B-4085EAE6321D
LiverTox ID	wds:Q28852444-05CB03C3-93DF-411F-8ABB-329E1882D7CC
LiverTox likelihood score	wds:Q28852444-D9B855AD-2744-4A7A-B131-06BFB26705E8
ATC code	B01AE01
defined daily dose	30 (xsd:decimal)
LiverTox ID	Desirudin
LiverTox likelihood score	LiverTox toxicity likelihood category E
instance of	wds:Q28852444-8675069a-4d12-f4b1-7d8b-019d59fa478d
instance of	type of chemical entity
subclass of	wds:Q28852444-f0ec3c1c-4841-fcb3-19e2-1bfe1f2ea44f
subclass of	peptide
has use	wds:Q28852444-03E0352F-509A-47FF-BBE7-CC3B8512DBE7
has use	medication
Probes And Drugs ID	wds:Q28852444-0BCCD782-29CF-4CFA-A196-B2A353D49E29
NDF-RT ID	wds:Q28852444-17A244A5-D6C6-41CE-9763-E21FFFBB7D3C
CAS Registry Number	wds:Q28852444-08A5B19C-33AA-455F-ACC4-9D9AD393223E
InChI	wds:Q28852444-aeac2986-4a95-f695-4e15-8992c03f56c5
InChIKey	wds:Q28852444-21777DC2-6B2F-4174-A6B4-AF186B1E8611
DSSTox substance ID	wds:Q28852444-6B402B8D-37E6-4591-8B64-9E33B098B6B2
RxNorm ID	wds:Q28852444-4A5892C0-E89C-4849-B373-110AD8899EE2
UNII	wds:Q28852444-0FFEF31A-0EC9-4DD4-8D25-BDB2E4D1778A
ChEBI ID	wds:Q28852444-D9FDD26F-E219-471F-B866-984D35F28960
DrugBank ID	wds:Q28852444-967B194E-E3E6-4856-82E6-5E880E8A762F
DSSTOX compound identifier	wds:Q28852444-3EE5115B-0EAE-4488-80A3-30052296E13B
NDF-RT ID	http://purl.bioontology.org/ontology/NDFRT/N0000188382
ChEBI ID	http://purl.obolibrary.org/obo/CHEBI_140427
Probes And Drugs ID	PD144057
NDF-RT ID	N0000188382
CAS Registry Number	120993-53-5
InChIKey	XYWBJDRHGNULKG-OUMQNGNKSA-N
DSSTox substance ID	DTXSID90153094
RxNorm ID	114934
UNII	U0JZ726775
ChEBI ID	140427
DrugBank ID	11095
DSSTOX compound identifier	DTXCID9075585
ChEMBL ID	wds:Q28852444-83DF8BA4-DE5C-4C42-A289-DD68F9AA59F2
ChEMBL ID	http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201662
ChEMBL ID	CHEMBL1201662
Guide to Pharmacology Ligand ID	wds:Q28852444-cd7d0505-4f8e-465a-edfa-064a1fc49e1e
Guide to Pharmacology Ligand ID	6458
skos:altLabel	cgp-39393 (en) desirudina (en) desirudinum (en) hirudin desirudin (en)
NCI Thesaurus ID	wds:Q28852444-9C92774C-021D-426F-88C5-3AE2DCBBC5B1
UNSPSC Code	wds:Q28852444-7B6D488E-3A13-4016-B733-56F776EE3D3C
MeSH descriptor ID	wds:Q28852444-E6AD84D8-0830-495A-982C-8169D7A7DC4E
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/C060225
NCI Thesaurus ID	C47473
UNSPSC Code	51131609
MeSH descriptor ID	C060225
active ingredient in	wds:Q28852444-C66DC3D3-59F5-44B2-A1C7-050FE0985920
active ingredient in	Revasc
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28852444
is main subject of	Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog model Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis. Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group). Safety of desirudin in thrombosis prevention after total knee arthroplasty: the DESIR-ABLE study Desirudin (Iprivask) for DVT prevention Hirudin CGP 39393 as thromboprophylaxis [Desirudin (Revasc) to prevent thromboembolic complications after hip or knee replacement surgery] Looking back into the future: desirudin in acute coronary syndromes and coronary stenting
is main subject of	wds:Q82285611-3DDD74B6-7A75-4D2C-B8DB-197D0683BA17 wds:Q54021999-1E03E855-B5D8-4C68-8502-44CCDD1F709D wds:Q71200405-B064D5FE-E99B-4842-ABC2-9D073B86D9CC wds:Q85943477-0592A000-425E-47F4-BB7C-1A172C41608A wds:Q72854982-687085EE-4669-4C8B-80DB-22A82AE407F7 wds:Q37935774-0109413A-9424-4341-944A-01C84209AC2B wds:Q45016452-884C9E03-C136-4746-90FD-F0479991CBDA wds:Q74384545-0FDAF1C9-2089-41E2-B163-7F8E7B1DD6AF wds:Q33395674-0D1A7724-E867-485B-BBC8-36C0CA20FF19 wds:Q53791589-3EC13B7B-32ED-490F-A8D9-90A4D0B049EA
is research intervention of	A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
is research intervention of	wds:Q64710195-9B389ECC-4FE5-4C60-AB09-35A426652C27 wds:Q65390962-29C80C8F-79E4-410D-BFAC-FA4CAE68E1E7 wds:Q65378422-FA47E8A7-4E60-4141-B5B5-C10222C1C198
is has active ingredient of	Revasc
is has active ingredient of	wds:Q29006430-280C56D4-A129-4CD3-A4EA-96D56A4BBE7B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software